Obicetrapib Works Synergistically with Ezetimibe in Statin Users, Study Finds
Christie Ballantyne, MD, discusses new data from the ROSE2 trial examining the potential synergistic effects of obicetrapib with ezetimibe in high-intensity statin users.
Stay updated with breaking news from Abbott Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Christie Ballantyne, MD, discusses new data from the ROSE2 trial examining the potential synergistic effects of obicetrapib with ezetimibe in high-intensity statin users.
The Joint Commission has appointed two new officers to their executive leadership team: Leslie Krohn, Chief Brand and Communications Officer, and Jason Miles, C
OAKBROOK TERRACE, Illinois, Dec. 19, 2023 (GLOBE NEWSWIRE) -- The Joint Commission Enterprise today announced two appointments to its executive...
Company says he has extensive board leadership experience and an exceptional track record in executive roles
Objective To evaluate the impact of implementing a high sensitivity assay for cardiac troponin I on long term outcomes in patients with suspected acute coronary syndrome. Design Secondary observational analysis of a stepped wedge, cluster randomised controlled trial. Setting 10 secondary and tertiary care centres in Scotland, UK. Participants 48 282 consecutive patients with suspected acute coronary syndrome. Myocardial injury was defined as any high sensitivity assay result for cardiac troponin I >99th centile of 16 ng/L in women and 34 ng/L in men. Intervention Hospital sites were rando...